(minimum–maximum)administeredactivitieswere225Ac-PSMA-617,5.3(1.5–7.9)MBq,and177Lu-PSMA-617,6.9(5.0–11.6)GBq.Significantresponderstotandemtherapyreceived177Lu-PSMA-617monotherapyasmaintenance(median[minimum–maximum]:1[0–5]cycle).Afteramedian(minimum–maximum)22(14–63)weeks’follow-up,13/20...
PSMA-ligand-1;又名PSMA-617;前列腺特异性膜抗原 (PSMA) 的强有效抑制剂 产品等级 优级品 产品规格 mg-g 产品类型 诊断试剂 储存条件 低温 有效成分含量 95% 保质期 12个月 器官来源 否 物种来源 100%人工合成 细胞形态 否 用途范围 科研服务 组织来源 否 是否是肿瘤细胞 否 是否进口 否 包装...
Ac-PSMA-617-targeted alpha therapy for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis225Ac‐PSMA‐617 TATmeta‐analysissystematic reviewBackground: The aim of this systematic review and meta゛nalysis was to present an overview of the role of ...
(25%), and grade 3/4 in 0/20.ConclusionsOur results suggest that a single course of tandem therapy with low-activity 225Ac-PSMA-617/full-activity 177Lu-PSMA-617 may safely enhance response to PRLT in men with late-stage/end-stage mCRPC while minimizing xerostomia severity. Formal study...
机译:225Ac-PSMA-617用于转移性去势抵抗性前列腺癌的PSMA靶向a放射治疗 获取原文 获取原文并翻译 | 示例 获取外文期刊封面目录资料 开具论文收录证明 >> 文献代查 >> 文献数据库(团队版) >> 页面导航 摘要 著录项 相似文献 相关主题 摘要 Prostate-specific membrane antigen (PSMA) is a promising target ...
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2019;46(1):129-38. Epub ... Sathekge, MikeBruchertseifer, FrankKnoesen, OttoReyneke, FloretteLawal, IsmaheelLengana, ThaboDavis, CindyMahapane, JohncyCorbett, CeceilaVo...
List of Drug Master Files (DMF) of 225 Ac-Psma-617 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website
225 Ac-PSMA-617/ 177 Lu-PSMA-617 Tandem Therapy of Metastatic Castration-Resistant Prostate Cancer: Pilot Experience 期刊名称: Nuklearmedizin 年份: 2020年 期号: 第02期 关键词: Metastatic castration-resistant prostate cancer;177Lu-PSMA-617 therapy;225Ac-PSMA-617 therapy;Tandem PSMA radioligand t...
CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer - ScienceDirectdoi:10.1016/j.ekir.2020.12.006Karyne PelletierGabrielle CtéNazanin Fallah-RadRohan JohnAbhijat KitchluKidney International Reports
225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer. J Nucl Med. 2016;57(12):1941-1944.Kratochwil C, Bruchertseifer F, Giesel FL, et al. 225Ac-PSMA-617 for PSMA- targeted ... B Hadaschik - 《European Urology》 被引量: 106发表: 20...